“Quantitative Structure Activity Relationship Studies of Potent Endothelin-A Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension”, IJC, vol. 63, no. 2, pp. 190–202, Feb. 2024, doi: 10.56042/ijc.v63i2.6141.